Evaluation of Concurrent Oral and Long-Acting Injectable Antipsychotic Prescribing at the Minneapolis Veterans Affairs Health Care System.
State-dependent microstructural white matter changes in drug-naïve patients with first-episode psychosis.
Cognitive clustering in schizophrenia patients, their first-degree relatives and healthy subjects is associated with anterior cingulate cortex volume.
Effectiveness of a treatment guideline for schizophrenia in adolescents: Lessons from a middle-income country.
Long-acting injectable antipsychotics update: lengthening the dosing interval and expanding the diagnostic indications.
Implications of infection and trends of antibiotic prescribing in hospitalized patients diagnosed with serious mental illness.
Neuregulin-1 (NRG1) polymorphisms linked with psychosis transition are associated with enlarged lateral ventricles and white matter disruption in schizophrenia.
The effects of repetitive transcranial magnetic stimulation on empathy: a systematic review and meta-analysis.
Steinberg and Durell (1968) revisited: increased rates of First Episode Psychosis following military induction in Greek Army Recruits.
Microarray gene-expression study in fibroblast and lymphoblastoid cell lines from antipsychotic-naïve first-episode schizophrenia patients.
Human Astrocyte Maturation Captured in 3D Cerebral Cortical Spheroids Derived from Pluripotent Stem Cells.
Comorbidity of schizophrenia and social phobia - impact on quality of life, hope, and personality traits: a cross sectional study.
TSH and PRL, side-effect markers in aripiprazole treatment: adjunctive aripiprazole-induced thyrotropin oversuppression in a young man with schizophrenia.
Dopaminergic responses in the core part of the nucleus accumbens to subcutaneous MK801 administration are increased following postnatal transient blockade of the prefrontal cortex.
Assessment of Needs: Differences between male and female patients with schizophrenia needs in psychiatric hospitals in Baghdad city.
Antipsychotic Use With and Without Comorbid Psychiatric Diagnosis Among Adults with Intellectual and Developmental Disabilities.
The nature and efficacy of culturally-adapted psychosocial interventions for schizophrenia: a systematic review and meta-analysis.
Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences.
A range of psycho-social and psychological interventions can support moderate improvements in negative symptoms in psychosis.
Negotiating the boundaries of psychosis: A qualitative study of the service provider perspective on treatment delay in community mental health.
Changes in antipsychotics and other psychotropic drugs during a 30-month lifestyle intervention among outpatients with schizophrenia.
Relationships between corpus callosum and language lateralization in patients with schizophrenia and bipolar disorders.
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis.
Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study.
GSTM1/GSTT1 double-null genotype increases risk of treatment-resistant schizophrenia: A genetic association study in Brazilian patients.
Neural responses to feedback information produced by self-generated or other-generated decision-making and their impairment in schizophrenia.
White noise speech illusion and psychosis expression: An experimental investigation of psychosis liability.
Is Forced Swimming Immobility a Good Endpoint for Modeling Negative Symptoms of Schizophrenia? - Study of Sub-Anesthetic Ketamine Repeated Administration Effects.
Body language reading of emotion in schizophrenia: Associations with symptoms and functional outcome.
Are experiences of psychosis associated with unhelpful metacognitive coping strategies? A systematic review of the evidence.
Erratum to: Incidence of schizophrenia among migrants in the Netherlands: a direct comparison of first contact and longitudinal register approaches.
No Evidence That Schizophrenia Candidate Genes Are More Associated With Schizophrenia Than Noncandidate Genes.
Prevalence and correlates of suboptimal vitamin D status in people living with psychotic disorders: Data from the Australian Survey of High Impact Psychosis.
Estimation of Symptom Severity Scores for Patients with Schizophrenia Using ERP Source Activations during a Facial Affect Discrimination Task.
The Utility of the Health Action Process Approach Model for Predicting Physical Activity Intentions and Behavior in Schizophrenia.
Speed and capacity of working memory and executive function in schizophrenia compared to unipolar depression.
Feasibility and preliminary efficacy of remotely delivering cognitive training to people with schizophrenia using tablets.
[New medical approach to out-of-hospital treatment of psychomotor agitation in psychiatric patients: a report of 14 cases].
Dopamine Transporter and Reward Anticipation in a Dimensional Perspective: A Multimodal Brain Imaging Study.
Short-Term Exposure to Enriched Environment in Adult Rats Restores MK-801-Induced Cognitive Deficits and GABAergic Interneuron Immunoreactivity Loss.
Interactions Between Variation in Candidate Genes and Environmental Factors in the Etiology of Schizophrenia and Bipolar Disorder: a Systematic Review.
Early psychosis in central Vietnam: A longitudinal study of short-term functional outcomes and their predictors.
The impracticality of surgically removing intramuscular long-acting injectable antipsychotic medication.
ErbB signaling antagonist ameliorates behavioral deficit induced by phencyclidine (PCP) in mice, without affecting metabolic syndrome markers.
Abnormal relationships between local and global brain measures in subjects at clinical high risk for psychosis: a pilot study.
Persistent increase in TNF and IL-1 markers in severe mental disorders suggests trait-related inflammation: a one year follow-up study.
Rodent Mismatch Negativity (MMN)/Theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia.
Compensatory cognitive training for people with severe mental illnesses in supported employment: A randomized controlled trial.
Cognitive effects with rivastigmine augmentation of risperidone: A 12-month, randomized, double-blind, placebo-controlled study in schizophrenia.
Progressive decline of cognition during the conversion from prodrome to psychosis with a characteristic pattern of the theory of mind compensated by neurocognition.
Understanding marijuana's effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation.
Abnormal long- and short-range functional connectivity in adolescent-onset schizophrenia patients: A resting-state fMRI study.
Copy number elevation of 22q11.2 genes arrests the developmental maturation of working memory capacity and adult hippocampal neurogenesis.
Metacognitive training in patients recovering from a first psychosis: an experience sampling study testing treatment effects.
Pharmacokinetic Limitations on Effects of an Alpha7 Nicotinic Receptor Agonist in Schizophrenia: Randomized Trial with an Extended Release Formulation.
Contrasting metacognitive, social cognitive and alexithymia profiles in adults with borderline personality disorder, schizophrenia and substance use disorder.
Physical activity and quality of life in long-term hospitalized patients with severe mental illness: a cross-sectional study.
On the brink of precision medicine for psychosis: Treating the patient, not the disease: A commentary on: Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment by Krivoj et al. 2017.
Differences in the impairment of insight between deficit syndrome and non-deficit syndrome patients with first-episode schizophrenia.
The differential effects of a focus on symptoms versus recovery in reducing stigma of schizophrenia.
Antioxidant Treatment in Male Mice Prevents Mitochondrial and Synaptic Changes in an NMDA Receptor Dysfunction Model of Schizophrenia.
Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia.
Effects of haloperidol, olanzapine, ziprasidone, and PHA-543613 on spatial learning and memory in the Morris water maze test in naïve and MK-801-treated mice.